Soc Telemed Inc Revenue Growth Rates (TLMD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Soc Telemed Inc   (NASDAQ: TLMD)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

TLMD's Revenue Growth by Quarter and Year

Soc Telemed Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TLMD Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
4th Quarter December 27.98
3rd Quarter September 26.68
2nd Quarter June 24.96
1st Quarter March 14.82
FY 94.44





TLMD Revenue fourth quarter 2021 Y/Y Growth Comment
Soc Telemed Inc achieved in the fourth quarter 2021, above Company average Revenue rise of 92.94% year on year, to $ 27.98 millions.

Looking into fourth quarter 2021 results within Healthcare Facilities industry 16 other companies have achieved higher Revenue growth. While Soc Telemed Inc ' s Revenue jump of 92.94% ranks overall at the positon no. 2441 in the fourth quarter 2021.


TLMD Revenue ( Y/Y Growth %) 2021
 2020 2019 2018
4th Quarter December 92.94 % 144900 % - -
3rd Quarter September 76.34 % - - -
2nd Quarter June 84.21 % - - -
1st Quarter March 0.07 % - - -
FY   62.85 % 579800 % - -

Financial Statements
Soc Telemed Inc 's fourth quarter 2021 Revenue $ 27.98 millions TLMD's Income Statement
Soc Telemed Inc 's fourth quarter 2020 Revenue $ 14.50 millions Quarterly TLMD's Income Statement


TLMD Revenue (Quarter on Quarter Growth %)

 2021
 2020 2019 2018
4th Quarter December 4.86 % -4.16 % - -
3rd Quarter September 6.89 % 11.66 % - -
2nd Quarter June 68.42 % -8.51 % - -
1st Quarter March 2.21 % 148000 % - -
FY (Year on Year)   62.85 % 579800 % - -


Back to TLMD Growth rate Comparisons >> Back to TLMD Growth rate Comparisons >>


Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #17
Healthcare Sector #350
Overall #2441

Revenue Y/Y Growth Statistics
High Average Low
86.12 % 74.48 % 62.85 %
(Sep 30 2021)   (Dec 31 2021)
Revenue fourth quarter 2021 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #17
Healthcare Sector #350
Overall #2441
Revenue Y/Y Growth Statistics
High Average Low
86.12 % 74.48 % 62.85 %
(Sep 30 2021)   (Dec 31 2021)

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Soc Telemed Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
147970 % 18506.42 % -8.46 %
(Mar 31 2020)  


TLMD's IV. Quarter Q/Q Revenue Comment
Soc Telemed Inc achieved in the IV. Quarter 2021 below company average Revenue growth of 4.86% quarter on quarter, to $ 27.98 millions.

IV. Quarter 2021 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -4.16% in the IV. Quarter a year ago.

Within Healthcare Facilities industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Soc Telemed Inc 's Revenue growth quarter on quarter, overall rank is 2247.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #21
Healthcare Sector #400
Overall #2247
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #21
Healthcare Sector #400
Overall #2247
Revenue Q/Q Growth Statistics
High Average Low
147970 % 18506.42 % -8.46 %
(Mar 31 2020)  


TLMD's IV. Quarter Q/Q Revenue Comment
Soc Telemed Inc achieved in the IV. Quarter 2021 below company average Revenue growth of 4.86% quarter on quarter, to $ 27.98 millions.

IV. Quarter 2021 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -4.16% in the IV. Quarter a year ago.

Within Healthcare Facilities industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Soc Telemed Inc 's Revenue growth quarter on quarter, overall rank is 2247.


Soc Telemed Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2021)		 12 Months Ending
(Sep 30 2021)		 12 Months Ending
(Jun 30 2021)		 12 Months Ending
 12 Months Ending
Cumulative Revenue 12 Months Ending $ 94.44 $ 80.97 $ 24.96 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) 62.85 % 86.12 % - - -
Year on Year Revenue Growth Overall Ranking # 538 # 0 # 0 # #
Seqeuential Revenue Change (TTM) 16.64 % 16.64 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 2441 # 0 # 0 # #


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2021 period, Soc Telemed Inc 's cumulative twelve months Revenue were $ 94 millions, company would post below average annual Revenue growth of 16.64% year on year, if the fiscal year would end at Dec 31 2021.
A slow-down in the Soc Telemed Inc 's Revenue growth from the 26.68% growth in Sep 30 2021.

In the Healthcare sector 139 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 538.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 17
Healthcare Sector # 140
Overall # 538

Revenue TTM Y/Y Growth Statistics
High Average Low
86.12 %
 74.48 %
62.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 350
S&P 500 # 2441
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2021 period, Soc Telemed Inc 's cumulative twelve months Revenue were $ 94 millions, company would post below average annual Revenue growth of 62.85% year on year, if the fiscal year would end at Dec 31 2021.
A slow-down in the Soc Telemed Inc 's Revenue growth from the 26.68% growth in Sep 30 2021.

In the Healthcare sector 139 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 538.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 17
Healthcare Sector # 140
Overall # 538

Revenue TTM Y/Y Growth Statistics
High Average Low
86.12 %
74.48 %
62.85 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 350
S&P 500 # 2441




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TLMD's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Dec 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2021
Caribou Biosciences Inc 160.06%$ 160.061 millions
Arcturus Therapeutics Holdings Inc 158.89%$ 158.892 millions
Sensus Healthcare Inc 155.67%$ 155.674 millions
Collplant Biotechnologies Ltd154.86%$ 154.864 millions
Biolife Solutions Inc 153.33%$ 153.327 millions
Dariohealth Corp 152.21%$ 152.212 millions
Cartesian Therapeutics Inc 150.50%$ 150.498 millions
Therapeutic Solutions International Inc 148.16%$ 148.160 millions
Icon Plc147.97%$ 147.968 millions
Checkpoint Therapeutics inc 146.39%$ 146.392 millions
Sellas Life Sciences Group Inc 146.00%$ 146.000 millions
Guided Therapeutics Inc 140.00%$ 140.000 millions
Revance Therapeutics Inc 133.09%$ 133.091 millions
Maravai Lifesciences Holdings Inc 132.27%$ 132.269 millions
Biodexa Pharmaceuticals Plc131.94%$ 131.937 millions
Sanuwave Health Inc 129.19%$ 129.195 millions
Gritstone Bio Inc 127.30%$ 127.300 millions
Societal Cdmo Inc 124.99%$ 124.987 millions
Prometheus Biosciences Inc 123.97%$ 123.974 millions
Asensus Surgical Inc 123.67%$ 123.668 millions
Concord Medical Services Holdings Ltd122.97%$ 122.968 millions
Xenetic Biosciences Inc 119.79%$ 119.795 millions
Beone Medicines Ltd 113.77%$ 113.765 millions
Lifemd Inc 112.64%$ 112.640 millions
Essa Pharma inc 108.97%$ 108.971 millions
Sangui Biotech International Inc107.37%$ 107.370 millions
Intra cellular Therapies Inc 106.12%$ 106.121 millions
Regeneron Pharmaceuticals Inc 104.37%$ 104.371 millions
Hims and Hers Health Inc 104.26%$ 104.261 millions
Urogen Pharma Ltd 103.04%$ 103.038 millions


About Soc Telemed Inc Revenue Growth Rates (TLMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Soc Telemed Inc (CIK 1791091).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-22-016288
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Soc Telemed Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.